Perfluorooctane sulfonate (PFOS) can alter the hypothalamic-pituitary-adrenal (HPA) axis activity by modifying CRF1 and glucocorticoid receptors. [electronic resource]
Producer: 20180827Description: 1-9 p. digitalISSN:- 1879-3169
- Adrenocorticotropic Hormone -- blood
- Alkanesulfonic Acids -- toxicity
- Animals
- Corticosterone -- blood
- Corticotropin-Releasing Hormone -- blood
- Dose-Response Relationship, Drug
- Down-Regulation
- Endocrine Disruptors -- toxicity
- Fluorocarbons -- toxicity
- Hypothalamo-Hypophyseal System -- drug effects
- Male
- Pituitary-Adrenal System -- drug effects
- RNA, Messenger -- genetics
- Rats, Sprague-Dawley
- Receptors, Corticotropin-Releasing Hormone -- drug effects
- Receptors, Glucocorticoid -- drug effects
- Signal Transduction -- drug effects
- Time Factors
- CRF Receptor, Type 1
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.